Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
pii: S1080-6032(18)30097-8
AMD070 hydrochloride
JNK phosphorylation and vascular smooth muscle cell proliferation via the induction of heme oxygenase-1
route of elimination and binding site on their target pancreatic β cell receptor
with IOP not returning to baseline until more than 8 h postdose
Vortioxetine hydrobromide troban pii: S1080-6032(18)30097-8Vortioxetine, also known as Lu AA21004, is an atypical antidepressant, and was approved in 2013 by the U. S. FDA for the treatment of major depressive disorder (MDD) in adults. Vortioxetine is a so called "serotonin modulator and stimulator." It has been shown to possess the following pharmacological actions: Serotonin transporter (SERT) blocker (i. e. serotonin reuptake inhibitor (SRI)) Ki (binding affinity) = 1. 6 nM, IC50 = 5. 4 nM; Norepinephrine